Answer
Cobicistat-containing medicines are expected to increase systemic side-effect risk from hydrocortisone sodium succinate; the combination should be avoided unless benefits outweigh the increased risk, in which case patients should be monitored for systemic corticosteroid side effects.
Sources for this answer
- Solu-Cortef/Hydrocortisone 100 mgPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 28Document updated
Sources checked